Nutex Health Inc.
NUTX
$122.90
$4.443.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 213.98% | 269.77% | 25.62% | 29.12% | 19.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 213.98% | 269.77% | 25.62% | 29.12% | 19.75% |
| Cost of Revenue | 66.37% | 113.84% | 1.95% | 8.60% | 11.84% |
| Gross Profit | 760.56% | 720.89% | 127.64% | 96.10% | 62.22% |
| SG&A Expenses | 429.79% | 200.20% | 50.80% | 5.81% | -4.06% |
| Depreciation & Amortization | 21.64% | 12.77% | 4.77% | 8.72% | 4.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 111.48% | 118.65% | 8.20% | 8.14% | 8.99% |
| Operating Income | 4,879.93% | 2,701.30% | 1,396.99% | 3,402.10% | 134.30% |
| Income Before Tax | 41,392.11% | 453.56% | 46.97% | 176.82% | 98.06% |
| Income Tax Expenses | 4,654.10% | 387.09% | 1,439.32% | 209.60% | 142.82% |
| Earnings from Continuing Operations | 8,259.23% | 460.75% | -58.38% | 170.56% | 92.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16,723.03% | -879.74% | -59.38% | -528.54% | -89.97% |
| Net Income | 4,120.33% | 295.13% | -58.56% | 89.54% | 92.93% |
| EBIT | 4,879.93% | 2,701.30% | 1,396.99% | 3,402.10% | 134.30% |
| EBITDA | 2,070.32% | 663.23% | 994.45% | 1,015.39% | 225.45% |
| EPS Basic | 3,631.96% | 257.73% | -37.84% | 90.78% | 93.67% |
| Normalized Basic EPS | 10,116.96% | 667.71% | 35.96% | 219.27% | 102.49% |
| EPS Diluted | 3,295.38% | 248.10% | -37.84% | 90.78% | 93.33% |
| Normalized Diluted EPS | 9,529.82% | 633.64% | 35.96% | 219.27% | 102.49% |
| Average Basic Shares Outstanding | 13.77% | 23.71% | 15.03% | 13.54% | 11.75% |
| Average Diluted Shares Outstanding | 20.71% | 31.61% | 15.03% | 13.54% | 11.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.38% | -- | -- | -- | -3.43% |